Christopher L Tinkle1, Israel Fernandez-Pineda2, April Sykes3, Zhaohua Lu3, Chia-Ho Hua1, Michael D Neel2, Armita Bahrami4, Barry L Shulkin5, Sue C Kaste5,6, Alberto Pappo7, Sheri L Spunt8, Matthew J Krasin1. 1. Department of Radiation Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee. 2. Department of Surgery, St. Jude Children's Research Hospital, Memphis, Tennessee. 3. Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee. 4. Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee. 5. Department of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis, Tennessee. 6. Department of Radiology, University of Tennessee Health Science Center, Memphis, Tennessee. 7. Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee. 8. Department of Pediatrics, Stanford University, Stanford, California.
Abstract
BACKGROUND: Indications for and delivery of adjuvant therapies for pediatric nonrhabdomyosarcoma soft tissue sarcoma (NRSTS) have been derived largely from adult studies; therefore, significant concern remains regarding radiation exposure to normal tissue. The authors report long-term treatment outcomes and toxicities for pediatric and young adult patients with high-grade NRSTS who were treated on a prospective trial using limited-margin radiotherapy. METHODS: Sixty-two patients (ages 3-22 years) with predominantly high-grade NRSTS requiring radiation were treated on a phase 2 institutional study of conformal external-beam radiotherapy and/or brachytherapy using a 1.5-cm to 2-cm anatomically constrained margin. The estimated cumulative incidence of local failure, Gray's method estimated cumulative incidence of local failure, Kaplan-Meier method estimated survival, competing-risk regression model determined predictors of disease outcome, and toxicity was reported according to CTCAE v2.0. RESULTS: At a median follow-up of 5.1 years (range, 0.2-10.9 years), 9 patients had experienced local failure. The 5-year overall cumulative incidence of local failure was 14.8% (95% confidence interval [CI], 7.2%-25%), and all but 1 local failure occurred outside the highest-dose irradiation volume. The 5-year Kaplan-Meier estimates for event-free and overall survival were 49.3% (95% CI, 36.3%-61.1%) and 67.9% (95% CI, 54.2%-78.3%), respectively. Multivariable analysis indicated that younger age was the only independent predictor of local recurrence (P = .004). The 5-year cumulative incidence of grade 3 or 4 late toxicity was 15% (95% CI, 7.2%-25.3%). CONCLUSIONS: The delivery of limited-margin radiotherapy using conformal external-beam radiotherapy or brachytherapy provides a high rate of local tumor control without an increase in marginal failures and with acceptable treatment-related morbidity. Cancer 2017;123:4419-29.
BACKGROUND: Indications for and delivery of adjuvant therapies for pediatric nonrhabdomyosarcoma soft tissue sarcoma (NRSTS) have been derived largely from adult studies; therefore, significant concern remains regarding radiation exposure to normal tissue. The authors report long-term treatment outcomes and toxicities for pediatric and young adult patients with high-grade NRSTS who were treated on a prospective trial using limited-margin radiotherapy. METHODS: Sixty-two patients (ages 3-22 years) with predominantly high-grade NRSTS requiring radiation were treated on a phase 2 institutional study of conformal external-beam radiotherapy and/or brachytherapy using a 1.5-cm to 2-cm anatomically constrained margin. The estimated cumulative incidence of local failure, Gray's method estimated cumulative incidence of local failure, Kaplan-Meier method estimated survival, competing-risk regression model determined predictors of disease outcome, and toxicity was reported according to CTCAE v2.0. RESULTS: At a median follow-up of 5.1 years (range, 0.2-10.9 years), 9 patients had experienced local failure. The 5-year overall cumulative incidence of local failure was 14.8% (95% confidence interval [CI], 7.2%-25%), and all but 1 local failure occurred outside the highest-dose irradiation volume. The 5-year Kaplan-Meier estimates for event-free and overall survival were 49.3% (95% CI, 36.3%-61.1%) and 67.9% (95% CI, 54.2%-78.3%), respectively. Multivariable analysis indicated that younger age was the only independent predictor of local recurrence (P = .004). The 5-year cumulative incidence of grade 3 or 4 late toxicity was 15% (95% CI, 7.2%-25.3%). CONCLUSIONS: The delivery of limited-margin radiotherapy using conformal external-beam radiotherapy or brachytherapy provides a high rate of local tumor control without an increase in marginal failures and with acceptable treatment-related morbidity. Cancer 2017;123:4419-29.
Authors: A M Davis; B O'Sullivan; R S Bell; R Turcotte; C N Catton; J S Wunder; P Chabot; A Hammond; V Benk; M Isler; C Freeman; K Goddard; A Bezjak; R A Kandel; A Sadura; A Day; K James; D Tu; J Pater; B Zee Journal: J Clin Oncol Date: 2002-11-15 Impact factor: 44.544
Authors: Kristy B Smith; Daniel J Indelicato; Jacquelyn A Knapik; Joanne P Lagmay; Christopher Morris; Jessica M Kirwan; Robert A Zlotecki; Mark T Scarborough; C Parker Gibbs; Robert B Marcus Journal: Int J Radiat Oncol Biol Phys Date: 2011-05-06 Impact factor: 7.038
Authors: Alberto Bossi; Ivo De Wever; Erik Van Limbergen; Bianca Vanstraelen Journal: Int J Radiat Oncol Biol Phys Date: 2006-11-02 Impact factor: 7.038
Authors: S W Lee; B A Fraass; L H Marsh; K Herbort; S S Gebarski; M K Martel; E H Radany; A S Lichter; H M Sandler Journal: Int J Radiat Oncol Biol Phys Date: 1999-01-01 Impact factor: 7.038
Authors: Chiaho Hua; Jonathan M Gray; Thomas E Merchant; Larry E Kun; Matthew J Krasin Journal: Int J Radiat Oncol Biol Phys Date: 2008-01-30 Impact factor: 7.038
Authors: Israel Fernandez-Pineda; M M Hudson; A S Pappo; M W Bishop; J L Klosky; T M Brinkman; D K Srivastava; M D Neel; B N Rao; A M Davidoff; K R Krull; D A Mulrooney; L L Robison; K K Ness Journal: J Cancer Surviv Date: 2016-06-04 Impact factor: 4.442
Authors: Aimee C Talleur; Fariba Navid; Sheri L Spunt; M Beth McCarville; John Wu; Shenghua Mao; Andrew M Davidoff; Michael D Neel; Matthew J Krasin Journal: Int J Radiat Oncol Biol Phys Date: 2016-04-12 Impact factor: 7.038
Authors: A Ferrari; G L De Salvo; B Brennan; M M van Noesel; A De Paoli; M Casanova; N Francotte; A Kelsey; R Alaggio; O Oberlin; M Carli; M Ben-Arush; C Bergeron; J H M Merks; M Jenney; M C Stevens; G Bisogno; D Orbach Journal: Ann Oncol Date: 2014-12-08 Impact factor: 32.976
Authors: Lynn Million; Andrea Hayes-Jordan; Yueh-Yun Chi; Sarah S Donaldson; Suzanne Wolden; Carol Morris; Stephanie Terezakis; Fran Laurie; Karen Morano; T J Fitzgerald; Torunn I Yock; David A Rodeberg; James R Anderson; Rose Anne Speights; Jennifer O Black; Cheryl Coffin; Mary Beth McCarville; Simon C Kao; Douglas S Hawkins; Sheri L Spunt; R Lor Randall Journal: Int J Radiat Oncol Biol Phys Date: 2021-02-03 Impact factor: 8.013